Atoltivimab
Product Specifications
CAS Number
2135632-29-8
Target
Virus Protease
Related Pathways
Microbiology/Virology
Bioactivity
Atoltivimab (REGN3470), also known as maftivimab/odesivimab (Inmazeb), represents the first monoclonal antibody approved by the Food and Drug Administration (FDA) to combat Zaire ebolavirus (EBOV) infection [1].
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS2121681-01 0.1 mL
Cy3-Linked Polyclonal Antibody to Gastric Intrinsic Factor (GIF)
Ask
View Details 
MBS2121681-02 0.2 mL
Cy3-Linked Polyclonal Antibody to Gastric Intrinsic Factor (GIF)
Ask
View Details MBS2121681-03 0.5 mL
Cy3-Linked Polyclonal Antibody to Gastric Intrinsic Factor (GIF)
Ask
View Details MBS2121681-04 1 mL
Cy3-Linked Polyclonal Antibody to Gastric Intrinsic Factor (GIF)
Ask
View Details